Symposium on Retinal Innovation

• 4.10.2013 | 7:30 AM - 5:30 PM
• Mandarin Oriental Hotel
  776 Boylston Street
  Boston, Massachusetts 02199

David Redlick

A full-day event bringing together world leaders of translational research in drug development, regenerative therapies, gene replacement and other treatments for retinal degenerative diseases and AMD with leaders from the life sciences investment world.

WilmerHale Partner David Redlick will moderate a panel titled “Pharma Collaborations and Alliances.”